AAAAAA

   
Results: 1-11 |
Results: 11

Authors: DEVITA G ZANNINI M CIRAFICI AM MELILLO RM DILAURO R FUSCO A SANTORO M
Citation: G. Devita et al., EXPRESSION OF THE RET PTC1 ONCOGENE IMPAIRS THE ACTIVITY OF TTF-1 ANDPAX-8 THYROID TRANSCRIPTION FACTORS/, Cell growth & differentiation, 9(1), 1998, pp. 97-103

Authors: SANTORO M MELILLO RM CARLOMAGNO F VISCONTI R DEVITA G SALVATORE G LUPOLI G FUSCO A VECCHIO G
Citation: M. Santoro et al., MOLECULAR-BIOLOGY OF THE MEN2 GENE, Journal of internal medicine, 243(6), 1998, pp. 505-508

Authors: CHIARIELLO M VISCONTI R CARLOMAGNO F MELILLO RM BUCCI C DEFRANCISCIS V FOX GM JING SQ COSO OA GUTKIND JS FUSCO A SANTORO M
Citation: M. Chiariello et al., SIGNALING OF THE RET RECEPTOR TYROSINE KINASE THROUGH THE C-JUN NH2-TERMINAL PROTEIN-KINASES (JNKS) - EVIDENCE FOR A DIVERGENCE OF THE ERKSAND JNKS PATHWAYS INDUCED BY RET, Oncogene, 16(19), 1998, pp. 2435-2445

Authors: CETTA F CHIAPPETTA G MELILLO RM PETRACCI M MONTALTO G SANTORO M FUSCO A
Citation: F. Cetta et al., THE RET PTC1 ONCOGENE IS ACTIVATED IN FAMILIAL ADENOMATOUS POLYPOSIS-ASSOCIATED THYROID PAPILLARY CARCINOMAS/, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 1003-1006

Authors: CARLOMAGNO F MELILLO RM VISCONTI R SALVATORE G DEVITA G LUPOLI G YU YB JING SQ VECCHIO G FUSCO A SANTORO M
Citation: F. Carlomagno et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR DIFFERENTIALLY STIMULATESRET MUTANTS ASSOCIATED WITH THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 SYNDROMES AND HIRSCHSPRUNGS-DISEASE, Endocrinology, 139(8), 1998, pp. 3613-3619

Authors: CIRAFICI AM SALVATORE G DEVITA G CARLOMAGNO F DATHAN NA VISCONTI R MELILLO RM FUSCO A SANTORO M
Citation: Am. Cirafici et al., ONLY THE SUBSTITUTION OF METHIONINE-918 WITH A THREONINE AND NOT WITHOTHER RESIDUES ACTIVATES RET TRANSFORMING POTENTIAL, Endocrinology, 138(4), 1997, pp. 1450-1455

Authors: CARLOMAGNO F SALVATORE G CIRAFICI AM DEVITA G MELILLO RM DEFRANCISCIS V BILLAUD M FUSCO A SANTORO M
Citation: F. Carlomagno et al., THE DIFFERENT RET-ACTIVATING CAPABILITY OF MUTATIONS OF CYSTEINE-620 OR CYSTEINE-634 CORRELATES WITH THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 DISEASE PHENOTYPE, Cancer research, 57(3), 1997, pp. 391-395

Authors: SANTORO M GRIECO M MELILLO RM FUSCO A VECCHIO G
Citation: M. Santoro et al., MOLECULAR DEFECTS IN THYROID CARCINOMAS - ROLE OF THE RET ONCOGENE INTHYROID NEOPLASTIC TRANSFORMATION, European journal of endocrinology, 133(5), 1995, pp. 513-522

Authors: FUSCO A SANTORO M GRIECO M CARLOMAGNO F DATHAN N FABIEN N BERLINGIERI MT LI Z DEFRANCISCIS V SALVATORE D MELILLO RM PORTELLA G CERRATO A COLANTUONI V VECCHIO G
Citation: A. Fusco et al., RET PTC ACTIVATION IN HUMAN THYROID CARCINOMAS/, Journal of endocrinological investigation, 18(2), 1995, pp. 127-129

Authors: GRIECO M CERRATO A SANTORO M FUSCO A MELILLO RM VECCHIO G
Citation: M. Grieco et al., CLONING AND CHARACTERIZATION OF H4 (D10S170), A GENE INVOLVED IN RET REARRANGEMENTS IN-VIVO, Oncogene, 9(9), 1994, pp. 2531-2535

Authors: MELILLO RM HELIN K LOWY DR SCHILLER JT
Citation: Rm. Melillo et al., POSITIVE AND NEGATIVE REGULATION OF CELL-PROLIFERATION BY E2F-1 - INFLUENCE OF PROTEIN LEVEL AND HUMAN PAPILLOMAVIRUS ONCOPROTEINS, Molecular and cellular biology, 14(12), 1994, pp. 8241-8249
Risultati: 1-11 |